Koninklijke Philips N.v. · EURONEXT:PHIA
Koninklijke Philips — Investor Day (2018)
13 slides from Koninklijke Philips's investor day presentation, 2018
Slide 1: Continuing the momentum to deliver improved performance
Continuing the momentum to deliver improved performance Robert Cascella Chief Business Leader Diagnosis & Treatment
Slide 2: Key takeaways
Key takeaways • Diagnosis & Treatment strategy is aligned with the Quadruple Aim • Gaining strong traction with new, differentiated solutions of systems, smart devices, software and services • Growing market share and profitability: – Image-Guided Therapy: Growing leadership in cardiovascular and br
Slide 3: Leading positions in Diagnosis & Treatment portfolio
Leading positions in Diagnosis & Treatment portfolio Image-Guided Therapy Ultrasound Diagnostic Imaging EUR 2.0 billion sales EUR 1.5 billion sales EUR 3.4 billion sales Deep integration with informatics and AI to drive productivity, diagnostic confidence and intelligent workflows1 #1 global player
Slide 4: Addressing attractive, minimally invasive surgery space – Strong traction with unique Image-Guided Therapy portfolio
Addressing attractive, minimally invasive surgery space – Strong traction with unique Image-Guided Therapy portfolio > 40% market On track to High-single-digit share in cath labs improve growth and systems and profitability high-teens gaining more with of the acquired profitability new applications
Slide 5: Image-Guided Therapy: Unique suite of innovative procedural solutions to support the right therapy delivery
Image-Guided Therapy: Unique suite of innovative procedural solutions to support the right therapy delivery in real-time Azurion combined with Entering into attractive Instant wave-Free Ratio– IntelliSpace Cardiology electrophysiology market Proven (iFR) Seamless workflow in the Breakthrough EPD ima
Slide 6: Significant value creation via growth in Ultrasound CV, GI, POC and OB/GYN
Significant value creation via growth in Ultrasound CV, GI, POC and OB/GYN Expanding OB/GYN gaining Double-digit leadership in share with OIT growth LTM cardio vascular advanced Q3 2018 through industry- applications in leading apps to women's health Gaining market drive efficiency share and diagnos
Slide 7: Ultrasound: Industry-leading, tailored applications and sharper imaging drive growth in the core and adjacencies
Ultrasound: Industry-leading, tailored applications and sharper imaging drive growth in the core and adjacencies Tailored applications Photo-realistic imaging Portable ultrasound Tailored applications, faster Superior diagnostic Exceptional portable data processing, sharper capabilities with photo-
Slide 8: Diagnostic Imaging gaining market share and improving profitability
Diagnostic Imaging gaining market share and improving profitability Our strategy is Investing in +120 bps market delivering value advanced share gain with built around solutions for strengthened go- innovation, precision to-market customer- diagnosis centricity, and productivity 70% portfolio Double
Slide 9: Diagnostic Imaging: Intelligent, AI-enabled applications combined with successful innovations in our systems platforms
Diagnostic Imaging: Intelligent, AI-enabled applications combined with successful innovations in our systems platforms MR Compressed SENSE IntelliSpace Portal Oncology Informatics Application enabling 50% Suite of applications enabling Deeper insights, confident faster scanning seamless workflow pat
Slide 10: IntelliSpace provides intelligent workflows, insights to enhance productivity and diagnostic confidence
IntelliSpace provides intelligent workflows, insights to enhance productivity and diagnostic confidence – less clicks, less time1 • Right image acquisition with intelligent support • Right image interpretation with informatics and AI • Right operational insights with informatics 10 1 31% faster work
Slide 11: New, innovative digital pathology and computational pathology
New, innovative digital pathology and computational pathology • Leadership with pathology lab chains worldwide • Computational pathology enabling accurate, reliable tumor estimation powered by Deep Learning • Tele-pathology addressing global staff shortage 11 Picture: IntelliSpace Oncology showing p
Slide 12: Integrating data across modalities to come to precision diagnosis and deliver on the Quadruple Aim
Integrating data across modalities to come to precision diagnosis and deliver on the Quadruple Aim Genomics Radiology Pathology Integrating patient data Oncology informatics with AI-enhanced decision support and treatment selection for tumor boards Radiology, pathology, genomics Addressing variation
Slide 13: Key takeaways
Key takeaways • Diagnosis & Treatment strategy is aligned with the Quadruple Aim • Gaining strong traction with new, differentiated solutions of systems, smart devices, software and services • Growing market share and profitability: – Image-Guided Therapy: Growing leadership in cardiovascular and br